Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2020-07-01
|
| Sraith: | Metabolites |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/2218-1989/10/8/314 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|